arrow
返回
L

Longying Jiang

Xiangya Hospital

21H指数
50论文数
1.7K被引数
收录论文 25
发表时间
A Hybrid compound H93 treats prostate cancer by directly binding UHRF1 and promoting protein dimerization一种混合化合物H93通过直接结合UHRF1并促进蛋白质二聚化来治疗前列腺癌
err2025-11-18
err0
errOAAI
errYuxin Fu; Longying Jiang; Guojian Xie; Yuchong Peng; Yongming Fu; Qianling Zhu; Youhong Liu; Guilong Zhao; Xueke Liu; Yongbo Peng; Yongheng Chen; Xiong Li
err分享
err收藏
Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4
err2024-03-01
err1
PREAI
errChen, Xiaojuan; Li, Huiliang; Lin, Qianmeng; Dai, Shuyan; Qu, Lingzhi; Guo, Ming; Zhang, Lin; Liao, Jiaxuan; Wei, Hudie; Xu, Guangyu; Jiang, Longying; Chen, Yongheng
err分享
err收藏
Predicting miRNA-Disease Associations by Combining Graph and Hypergraph Convolutional Network
err2024-01-29
err7
PREAI
errLiang, Xujun; Guo, Ming; Jiang, Longying; Fu, Ying; Zhang, Pengfei; Chen, Yongheng
err分享
err收藏
Structural insights into the HDAC4-MEF2A-DNA complex and its implication in long-range transcriptional regulation
err2024-01-28
err2
errOAAI
errDai, Shuyan; Guo, Liang; Dey, Raja; Guo, Ming; Zhang, Xiangqian; Bates, Darren; Cayford, Justin; Jiang, Longying; Wei, Hudie; Chen, Zhuchu; Zhang, Ye; Chen, Lin; Chen, Yongheng
err分享
err收藏
Real-world outcomes of first-line tislelizumab plus axitinib in patients with metastatic non-clear cell renal cell carcinoma (mnccRCC)
err2023-11-01
err0
PREAI
errHuang, T.; Jiang, L.; Wei, W.; Zheng, X.; Zhang, Z.; Guo, S.; Han, H.; Cai, X.; Zhou, F.; Dong, P.
err分享
err收藏
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
err2023-07-18
err27
errOAAI
errWei, Hudie; Wang, Haolan; Wang, Genxin; Qu, Lingzhi; Jiang, Longying; Dai, Shuyan; Chen, Xiaojuan; Zhang, Ye; Chen, Zhuchu; Li, Youjun; Guo, Ming; Chen, Yongheng
err分享
err收藏
Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor芳香烃受体配体结合机制的结构洞察
err2022-10-20
err18
errOAAI
errDai, Shuyan; Qu, Lingzhi; Li, Jun; Zhang, Ye; Jiang, Longying; Wei, Hudie; Guo, Ming; Chen, Xiaojuan; Chen, Yongheng
err分享
err收藏
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants
err2022-08-22
err23
errOAAI
errLin, Qianmeng; Chen, Xiaojuan; Qu, Lingzhi; Guo, Ming; Wei, Hudie; Dai, Shuyan; Jiang, Longying; Chen, Yongheng
err分享
err收藏
Structure-based design of a dual-warhead covalent inhibitor of FGFR4 (vol 5, 36, 2022)
err2022-04-14
err1
errOAAI
errChen, Xiaojuan; Li, Huiliang; Lin, Qianmeng; Dai, Shuyan; Yue, Sitong; Qu, Lingzhi; Li, Maoyu; Guo, Ming; Wei, Hudie; Li, Jun; Jiang, Longying; Xu, Guangyu; Chen, Yongheng
err分享
err收藏
Structure-based design of a dual-warhead covalent inhibitor of FGFR4
err2022-03-17
err14
errOAAI
errChen, Xiaojuan; Li, Huiliang; Lin, Qianmeng; Dai, Shuyan; Yue, Sitong; Qu, Lingzhi; Li, Maoyu; Guo, Ming; Wei, Hudie; Li, Jun; Jiang, Longying; Xu, Guangyu; Chen, Yongheng
err分享
err收藏
Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors
err2022-01-11
err14
errOAAI
errQu, Lingzhi; Chen, Xiaojuan; Wei, Hudie; Guo, Ming; Dai, Shuyan; Jiang, Longying; Li, Jun; Yue, Sitong; Chen, Zhuchu; Chen, Yongheng
err分享
err收藏
Recent advances in systemic therapy for hepatocellular carcinoma
err2022-01-09
err133
errOAAI
errZhang, Huajun; Zhang, Wuyang; Jiang, Longying; Chen, Yongheng
err分享
err收藏
Befotertinib versus icotinib as first-line treatment in patients with advanced or metastatic EGFR-mutated non-small cell lung cancer: A multicenter, randomized, open-label, controlled phase III study
err2021-09-01
err1
errOAAI
errLu, S.; Zhou, J.; Jian, H.; Wu, L.; Cheng, Y.; Fan, Y.; Fang, J.; Chen, G.; Zhang, Z.; Lv, D.; Jiang, L.; Wu, R.; Jin, X.; Zhang, X.; Zhang, J.; Sun, G.; Huang, D.; Cui, J.; Guo, R.; Ding, L.
err分享
err收藏
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosisp53-mediated线粒体凋亡分子机制的结构洞察
err2021-04-16
err58
errOAAI
errWei, Hudie; Qu, Lingzhi; Dai, Shuyan; Li, Yun; Wang, Haolan; Feng, Yilu; Chen, Xiaojuan; Jiang, Longying; Guo, Ming; Li, Jun; Chen, Zhuchu; Chen, Lin; Zhang, Ye; Chen, Yongheng
err分享
err收藏
Mechanism of forkhead transcription factors binding to a novel palindromic DNA site
err2021-02-12
err32
errOAAI
errLi, Jun; Dai, Shuyan; Chen, Xiaojuan; Liang, Xujun; Qu, Lingzhi; Jiang, Longying; Guo, Ming; Zhou, Zhan; Wei, Hudie; Zhang, Huajun; Chen, Zhuchu; Chen, Lin; Chen, Yongheng
err分享
err收藏
Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements核受体NR4A2的同二聚体与选择性Nur响应DNA元件结合的结构基础
err2019-12-01
err23
errOAAI
errJiang, Longying; Dai, Shuyan; Li, Jun; Liang, Xujun; Qu, Lingzhi; Chen, Xiaojuan; Guo, Ming; Chen, Zhuchu; Chen, Lin; Wei, Hudie; Chen, Yongheng
err分享
err收藏
Structural basis for DNA recognition by FOXC2
err2019-02-05
err43
errOAAI
errChen, Xiaojuan; Wei, Hudie; Li, Jun; Liang, Xujun; Dai, Shuyan; Jiang, Longying; Guo, Ming; Qu, Lingzhi; Chen, Zhuchu; Chen, Lin; Chen, Yongheng
err分享
err收藏
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared with Chemoradiotherapy in Locally Advanced Gastric Adenocarcinoma
err2018-11-01
err4
PREAI
errWang, X.; Jin, J.; Zhao, D. B.; Chi, Y. H. B. L.; Yang, L.; Jiang, L.; Dou, L. Z.; Tang, Y.; Li, N.; Liu, W., Jr.; Tian, Y. T.; Zhao, H.; Che, X.; Bai, X. F.; Lu, N.; Hua, R.; Fang, H.; Wang, S. L.; Song, Y. W.; Liu, Y.; Li, Y. X.
err分享
err收藏
LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance
err2018-01-01
err56
PREAI
errWu, Daichao; Guo, Ming; Min, Xiaoli; Dai, Shuyan; Li, Meixiang; Tan, Sijie; Li, Guoqing; Chen, Xiaojuan; Ma, Yao; Li, Jun; Jiang, Longying; Qu, Lingzhi; Zhou, Zhan; Chen, Zhuchu; Chen, Lin; Xu, Guangyu; Chen, Yongheng
err分享
err收藏